Paweł Krawczyk

2.7k total citations
168 papers, 1.8k citations indexed

About

Paweł Krawczyk is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Paweł Krawczyk has authored 168 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Pulmonary and Respiratory Medicine, 81 papers in Oncology and 49 papers in Molecular Biology. Recurrent topics in Paweł Krawczyk's work include Lung Cancer Treatments and Mutations (74 papers), Lung Cancer Research Studies (39 papers) and Cancer Immunotherapy and Biomarkers (29 papers). Paweł Krawczyk is often cited by papers focused on Lung Cancer Treatments and Mutations (74 papers), Lung Cancer Research Studies (39 papers) and Cancer Immunotherapy and Biomarkers (29 papers). Paweł Krawczyk collaborates with scholars based in Poland, Sweden and United States. Paweł Krawczyk's co-authors include Janusz Milanowski, Kamila Wojas‐Krawczyk, Anna Grenda, Tomasz Powrózek, Marcin Nicoś, Tomasz Kucharczyk, Dariusz M. Kowalski, Ewa Kalinka‐Warzocha, Michał Szczyrek and Radosław Mlak and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Paweł Krawczyk

159 papers receiving 1.8k citations

Peers

Paweł Krawczyk
Yuanyuan Lei China
Joanna Chorostowska‐Wynimko Poland
Pei Zhang China
Qibin Song China
Bangwei Cao China
Jingli Zhang China
Xingyu Liu China
Yuanyuan Lei China
Paweł Krawczyk
Citations per year, relative to Paweł Krawczyk Paweł Krawczyk (= 1×) peers Yuanyuan Lei

Countries citing papers authored by Paweł Krawczyk

Since Specialization
Citations

This map shows the geographic impact of Paweł Krawczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Krawczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Krawczyk more than expected).

Fields of papers citing papers by Paweł Krawczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paweł Krawczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Krawczyk. The network helps show where Paweł Krawczyk may publish in the future.

Co-authorship network of co-authors of Paweł Krawczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Paweł Krawczyk. A scholar is included among the top collaborators of Paweł Krawczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paweł Krawczyk. Paweł Krawczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicoś, Marcin, Anna Sroka‐Bartnicka, Ewa Kalinka‐Warzocha, & Paweł Krawczyk. (2025). Possibilities of Overcoming Resistance to Osimertinib in NSCLC Patients with Mutations in the EGFR Gene. Cancers. 17(4). 563–563. 1 indexed citations
2.
Nicoś, Marcin, Izabela Chmielewska, Barbara Kuźnar-Kamińska, et al.. (2025). Application of Fourier transform infrared (FTIR) spectroscopy in liquid biopsy to predict the response to the first-line immunotherapy in non-small-cell lung cancer (NSCLC) patients. Biochemical and Biophysical Research Communications. 771. 152007–152007.
3.
Gaweł, Kinga, Marta Marszałek‐Grabska, Anna Grenda, et al.. (2024). Induction of seizures and initiation of epileptogenesis by pilocarpine in zebrafish larvae. Frontiers in Molecular Neuroscience. 17. 1418606–1418606. 2 indexed citations
4.
Krawczyk, Paweł, et al.. (2024). Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection. International Journal of Molecular Sciences. 25(11). 5893–5893. 25 indexed citations
5.
6.
7.
Strzemski, Maciej, et al.. (2023). Effectiveness of ALK inhibitors in treatment of CNS metastases in NSCLC patients. Annals of Medicine. 55(1). 1018–1028. 8 indexed citations
8.
Krawczyk, Paweł, et al.. (2022). The efficacy of T790M mutation testing in liquid biopsy—Real clinic data. PLoS ONE. 17(5). e0267846–e0267846. 2 indexed citations
9.
Wojas‐Krawczyk, Kamila, et al.. (2022). Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures. International Journal of Molecular Sciences. 23(4). 2261–2261. 7 indexed citations
10.
Grenda, Tomasz, Anna Grenda, Piotr Domaradzki, Paweł Krawczyk, & K. Kwiatek. (2022). Probiotic Potential of Clostridium spp.—Advantages and Doubts. Current Issues in Molecular Biology. 44(7). 3118–3130. 34 indexed citations
11.
Chmielewska, Izabela, et al.. (2022). Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with EGFR Gene Mutation–Case Report and a Literature Review. Current Oncology. 29(5). 3531–3539. 7 indexed citations
12.
Nicoś, Marcin & Paweł Krawczyk. (2022). Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer. Cancers. 14(7). 1813–1813. 4 indexed citations
13.
Kołodziej, Przemysław, Marcin Nicoś, Paweł Krawczyk, et al.. (2021). The Correlation of Mutations and Expressions of Genes within the PI3K/Akt/mTOR Pathway in Breast Cancer—A Preliminary Study. International Journal of Molecular Sciences. 22(4). 2061–2061. 10 indexed citations
14.
Wojas‐Krawczyk, Kamila, et al.. (2021). Two Complementarity Immunotherapeutics in Non-Small-Cell Lung Cancer Patients—Mechanism of Action and Future Concepts. Cancers. 13(11). 2836–2836. 3 indexed citations
15.
Szczyrek, Michał, Anna Grenda, Barbara Kuźnar-Kamińska, et al.. (2021). Methylation of DROSHA and DICER as a Biomarker for the Detection of Lung Cancer. Cancers. 13(23). 6139–6139. 5 indexed citations
16.
Wojas‐Krawczyk, Kamila, et al.. (2021). Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer. International Journal of Molecular Sciences. 22(16). 9030–9030. 38 indexed citations
17.
18.
Nicoś, Marcin, Paweł Krawczyk, Kamila Wojas‐Krawczyk, et al.. (2017). Evaluation of ALK gene rearrangement in central nervous system metastases of non-small-cell lung cancer using two-step RT-PCR technique. Clinical & Translational Oncology. 19(12). 1447–1453. 2 indexed citations
19.
Kieszko, Robert, et al.. (2013). Good’s syndrome twelve years after thymectomy due to thymoma. A case study. Central European Journal of Immunology. 38(4). 505–510. 1 indexed citations
20.
Mlak, Radosław, Paweł Krawczyk, & Janusz Milanowski. (2010). Czynniki biochemiczne i genetyczne w diagnostyce i prognozowaniu przebiegu chorób nowotworowych. Via Medica Journals.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuanyuan Lei Breakdown of academic impact, for papers by Joanna Chorostowska‐Wynimko Breakdown of academic impact, for papers by Pei Zhang Breakdown of academic impact, for papers by Qibin Song Breakdown of academic impact, for papers by Bangwei Cao Breakdown of academic impact, for papers by Jingli Zhang Breakdown of academic impact, for papers by Xingyu Liu
Rankless by CCL
2026